LABD
Direxion Daily S&P Biotech Bear 3X Shares
Price Chart
Latest Quote
$9.14
-0.55 (-5.68%)
Current Price
| Previous Close | $9.69 |
| Open | $9.56 |
| Day High | $9.56 |
| Day Low | $8.75 |
| Volume | 9,348,579 |
Fund Information
| Quarterly Dividend / Yield | N/A / 7.39% |
| Net Assets | $77.29M |
| Expense Ratio | 1.07% |
| Category | Trading--Inverse Equity |
| Fund Family | Direxion Funds |
| Net Asset Value | $9.16 |
| Premium/Discount | -0.19% |
| Quarterly Dividend Yield | 7.39% |
| Exchange | PCX |
📊 ETF Analysis
Company Data
Financial Ratios
Returns & Margins
Ownership
| Insider & Institutional transactions data not available |
Valuation Ratios
Analyst Data
Technical Indicators
| SMA20 | $12.62 |
| SMA50 | $13.38 |
| SMA200 | $21.84 |
| RSI | 26.93 |
| ATR | 1.2393 |
| Rel Volume | 1.72 |
Performance History
| Week | -23.32% |
| Month | -35.37% |
| Quarter | -52.25% |
| 6 Months | -53.42% |
| YTD | -58.08% |
| Year | -87.42% |
| 3 Years | -92.06% |
| 5 Years | -94.96% |
| 10 Years | -99.99% |
ETF Scoring Not Available
Exchange-traded funds (ETFs) are not scored using our fundamental analysis metrics, as they represent baskets of securities rather than individual companies.
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-25 | $8.82 | 12,111,670 |
| 2026-06-24 | $9.14 | 9,385,900 |
| 2026-06-23 | $9.69 | 6,470,700 |
| 2026-06-22 | $9.93 | 13,223,700 |
| 2026-06-18 | $11.21 | 6,126,700 |
| 2026-06-17 | $11.50 | 8,682,900 |
| 2026-06-16 | $12.60 | 4,474,900 |
| 2026-06-15 | $12.34 | 6,701,700 |
| 2026-06-12 | $13.09 | 7,104,500 |
| 2026-06-11 | $13.38 | 8,914,800 |
| 2026-06-10 | $14.74 | 5,408,400 |
| 2026-06-09 | $13.90 | 4,798,700 |
| 2026-06-08 | $14.93 | 5,512,300 |
| 2026-06-05 | $14.83 | 5,834,300 |
| 2026-06-04 | $13.38 | 6,714,200 |
| 2026-06-03 | $14.60 | 6,170,800 |
| 2026-06-02 | $15.32 | 6,421,000 |
| 2026-06-01 | $13.52 | 5,814,200 |
| 2026-05-29 | $12.67 | 5,390,100 |
| 2026-05-28 | $12.90 | 5,854,700 |
| 2026-05-27 | $13.32 | 6,646,100 |
| 2026-05-26 | $13.65 | 4,541,000 |
About Direxion Daily S&P Biotech Bear 3X Shares
The fund, under normal circumstances, invests at least 80% of the fund’s net assets in financial instruments, including swap agreements, futures contracts, or short positions, that, in combination, provide 3X daily inverse (opposite) or short exposure to the index or to ETFs that track the index, consistent with the fund’s investment objective. The index is designed to measure the performance of the biotechnology sub-industry based on the GICS. The fund is non-diversified.
📰 Latest News
No news articles available at the moment. Check back later for updates on LABD.
Period:
Loading...
No financial data available yet. Financial data will be fetched automatically.